{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:19:45Z","timestamp":1791379185943,"version":"4.3.2"},"reference-count":46,"publisher":"MedWorks Media","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Mood and anxiety disorders are leading causes of psychiatric hospitalization. However, data on real-world inpatient psychopharmacologic practices in the Philippines are limited. This study aims to describe the clinical characteristics and psychotropic medication prescribing patterns among inpatients with mood and anxiety disorders at a tertiary private hospital in the Philippines. This retrospective descriptive study reviewed medical records of patients admitted to the Section of Psychiatry at Makati Medical Center from January 1, 2014, to December 31, 2017. Patients with a primary DSM-5 diagnosis of bipolar disorder (BD), major depressive disorder (MDD), or anxiety disorder (AD) were included. Demographic and clinical characteristics, suicidality, and psychotropic prescribing patterns were summarized using descriptive statistics. A total of 705 patients were included: 350 (49.6%) with BD, 301 (42.7%) with MDD, and 54 (7.7%) with AD. Depressed mood was the most common presentation at admission (58.6%), and 72.2% of patients were euthymic at discharge. Suicide attempts were documented in more than half of patients with available data. Valproate, quetiapine, clonazepam, and aripiprazole were the most frequently prescribed medications for BD. In MDD, clonazepam, escitalopram, quetiapine, and aripiprazole predominated, while clonazepam and selective serotonin reuptake inhibitors were most commonly used in AD. Polypharmacy was frequent across diagnostic groups. Psychopharmacologic management of hospitalized patients with mood and anxiety disorders in this Philippine tertiary center largely aligns with international practice. High rates of polypharmacy and suicidality underscore the need for optimized, evidence-based prescribing and longitudinal outcome studies.<\/jats:p>","DOI":"10.64719\/pb.16584","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:16:27Z","timestamp":1773260187000},"page":"68-93","source":"Crossref","is-referenced-by-count":1,"title":["A Retrospective Study of d and Anxiety isorders anagement rofile (MooD-MaP) of Patients Admitted at the Makati Medical Center from 2014\u20132017"],"prefix":"10.64719","volume":"56","author":[{"given":"Carmina Charmaine G","family":"Bernardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Angela O","family":"Leynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia Grace","family":"Benosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine Freyja","family":"Linsangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin Myan","family":"Dantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vichka Claire","family":"Sison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ormalyn","family":"Bayting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Whiteford HA, Degenhardt L, Rehm J et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575\u20131586.","DOI":"10.1016\/S0140-6736(13)61611-6"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016;3:171\u2013178.","DOI":"10.1016\/S2215-0366(15)00505-2"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Steel Z, Marnane C, Iranpour C et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980\u20132013. Int J Epidemiol. 2014;43:476\u2013493.","DOI":"10.1093\/ije\/dyu038"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kleinman L, Lowin A, Flood E et al. Costs of bipolar disorder. Pharmacoeconomics. 2003;21:601\u2013622.","DOI":"10.2165\/00019053-200321090-00001"},{"key":"ref5","unstructured":"Woods SW. The economic burden of bipolar disease. J Clin Psychiatry. 2000;13:38\u201341."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness \u2013 1991. Soc Psychiatry Psychiatr Epidemiol. 1995;30:213\u2013219.","DOI":"10.1007\/BF00789056"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Cloutier M, Greene M, Ceverin A et al. The economic burden of bipolar 1 disorder in the United States in 2015. J Affect Disord. 2018;226:45\u201351.","DOI":"10.1016\/j.jad.2017.09.011"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Nabavi B, Mitchell AJ, Nutl D. A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: a meta-analysis of 52 interview-based studies of psychiatric population. EBioMedicine. 2015;2:1405\u20131419.","DOI":"10.1016\/j.ebiom.2015.09.006"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Holtzman JN, Lolich M, Ketter TA et al. Clinical characteristics of bipolar disorder: a comparative study between Argentina and the United States. Int J Bipolar Disord. 2015;3:8.","DOI":"10.1186\/s40345-015-0027-z"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Hawke LD, Provencher MD, Parikh SV et al. Comorbid anxiety disorders in Canadians with bipolar disorder: clinical characteristics and service use. Can J Psychiatry. 2013;58(7):393\u2013401.","DOI":"10.1177\/070674371305800704"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kupfer DJ, Frank E, Grochocinski VJ et al. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63(2):120\u2013125.","DOI":"10.4088\/JCP.v63n0206"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Hasin DS, Sarvet AL, Meyres JL et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. [Accessed on 05\/30\/2018]; JAMA Psychiatry. 2018 75(4):336\u2013346. doi: 10.1001\/jamapsychiatry.2017.4602.","DOI":"10.1001\/jamapsychiatry.2017.4602"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Craske MG, Stein MD. Anxiety (seminar) The Lancet. 2016;388(10063):3048\u20133059.","DOI":"10.1016\/S0140-6736(16)30381-6"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Hawke LD, Parikh SV, Michalak EE. Stigma and bipolar disorder: a review of the literature. J Affect Disord. 2013;150:181\u2013191.","DOI":"10.1016\/j.jad.2013.05.030"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"IsHak WW, Brown K, Aye SS et al. Health-related quality of life in bipolar disorder. Bipolar Disord. 2012;14:6\u201318.","DOI":"10.1111\/j.1399-5618.2011.00969.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Magalh\u00e3es PV, Kapczinski F, Nierenberg AA et al. Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Acta Psychiat Scand. 2012;125:303\u2013308.","DOI":"10.1111\/j.1600-0447.2011.01794.x"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Cerimele JM, Chan YF, Chwastiak LA et al. Bipolar disorder in primary care: clinical characteristics of 740 primary care patients with bipolar disorder. Psychiatric Services. 2014;65(8):1041\u20131046.","DOI":"10.1176\/appi.ps.201300374"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Fagiolini A, Frank E, Rucci P et al. Mood and anxiety spectrum as a means to identify clinically relevant subtypes of bipolar disorder. Bipolar Disord. 2007;9:462\u2013467.","DOI":"10.1111\/j.1399-5618.2007.00443.x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Simon NM, Otto MW, Wisniewski S et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first participants in the Systemic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Am J Psychiatry. 2004;161:2222\u20132229.","DOI":"10.1176\/appi.ajp.161.12.2222"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ketter TA. Recognizing the extent of overlap between bipolar disorder and anxiety disorders (commentary) EBioMedicine. 2015;2:1284\u20131285.","DOI":"10.1016\/j.ebiom.2015.09.022"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Otto MW, Simon NM, Wisniewski SR et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006;189:20\u201325.","DOI":"10.1192\/bjp.bp.104.007773"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Monteith S, Glenn T, Geddes J et al. Big data for bipolar disorder. Int J Bipolar Disord. 2016;4:10.","DOI":"10.1186\/s40345-016-0051-7"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Monteith S, Glenn T, Geddes J et al. Big data are coming to psychiatry: a general introduction. Int J Bipolar Disord. 2015;3:21.","DOI":"10.1186\/s40345-015-0038-9"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Altman RB, Ashley EA. Using \u201cbig data\u201d to dissect clinical heterogeneity. Circulation. 2015;131:232\u2013233.","DOI":"10.1161\/CIRCULATIONAHA.114.014106"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hripcsak G, Albers DJ. Next generation phenotyping of electronic health records. Am J Med Inform Assoc. 2013;20:117\u2013121.","DOI":"10.1136\/amiajnl-2012-001145"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Castro VM, Minnier J, Murphy SN et al. Validation of electronic health record phenotyping of bipolar cases and controls. Am J Psychiatry. 2015;172:363\u2013372.","DOI":"10.1176\/appi.ajp.2014.14030423"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"McIntyre RS, Cha DS, Jerrell JM et al. Advancing biomarker research: utilizing \u201cbig data\u201d approaches for the characterization and prevention of bipolar disorder. Bipolar Disord. 2014;16:531\u2013547.","DOI":"10.1111\/bdi.12162"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Henry C, Andreassen OA, Barbato A et al. European network of bipolar research expert centre (ENBREC): a network to foster research and promote innovative care. Int J Bipolar Disord. 2013;1:2.","DOI":"10.1186\/2194-7511-1-2"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Allebeck P. The use of population-based registers in psychiatric research. Acta Psychiatr Scand. 2009;120:386\u2013391.","DOI":"10.1111\/j.1600-0447.2009.01474.x"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Merikangas KR, Jin R, He JP et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychaitry. 2011;68(3):241\u2013251.","DOI":"10.1001\/archgenpsychiatry.2011.12"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Weissman MM, Bland RC, Canino GJ et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276(4):293\u2013299.","DOI":"10.1001\/jama.1996.03540040037030"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Post RM, Kupka R, Keck PE, Jr et al. Further evidence of a cohort effect in bipolar disorder: more early onsets and family history of psychiatric illness in more recent epochs. J Clin Psychiatry. 2016;77(8):1043\u20131049.","DOI":"10.4088\/JCP.15m10121"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kupfer DJ, Frank E, Grochocinski VJ et al. African-American participants in a bipolar registry: clinical and treatment characteristics. Bipolar Disord. 2005;7:82\u201388.","DOI":"10.1111\/j.1399-5618.2004.00163.x"},{"key":"ref34","unstructured":"Del Valle TR, Mapa RR, Paccial RC et al. Consensus treatment guidelines on schizophrenia in adults. Philippine Journal of Psychiatry. 2017;39(2[supplement]):2\u201369."},{"key":"ref35","unstructured":"Sionzon MP, Bautista TD, Castro CP et al. Consensus treatment guidelines on bipolar mood disorder. Philippine Journal of Psychiatry. 2017;39(2[supplement]):2\u201340."},{"key":"ref36","unstructured":"Leynes EA, Lantano AM, Casta\u00f1eda RF et al. Consensus treatment guidelines on major depressive disorder. Philippine Journal of Psychiatry. 2017;39(2[supplement]):2, 93."},{"key":"ref37","unstructured":"Nubla-Gestuvo BE, Mari\u00f1as MM, Lising-Enriquez AK et al. Consensus treatment guidelines on anxiety (panic disorder, generalized anxiety disorder, social anxiety disorder) Philippine Journal of Psychiatry. 2017;39(2[supplement]):2\u201363."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Kennedy SH, Lam RW, McIntyre RS et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder. Section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540\u2013560.","DOI":"10.1177\/0706743716659417"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Yatham LN, Kennedy SH, Parikh SV et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;1","DOI":"10.1111\/bdi.12025"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Malhi GS, Bassett D, Boyce P et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49(12):1\u2013185.","DOI":"10.1177\/0004867415617657"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth edition. 2013 Arlington, VA. American Psychiatric Association.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Verdolini N, Perugi G, Samalin L et al. Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features. Acta Psychiatr Scand. 2017;136(4) doi: 10.1111\/acps.12777.","DOI":"10.1111\/acps.12777"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Hyland P, Shevlin M, Elklit A et al. Social, familial and psychological risk factors for mood and anxiety disorders in childhood and early adulthood: a birth cohort study using the Danish registry system. Soc Psychiatry Psychiatr Epidemiol. 2016;15:331\u2013338.","DOI":"10.1007\/s00127-016-1171-1"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Reinares M, Bonnin CM, Hidalgo-Mazzei D et al. Family functioning in bipolar disorder: characteristics, congruity between patients and relatives, and clinical correlates. Psychiatry Research. doi: 10.1016\/j.psychres.2016.08.010.","DOI":"10.1016\/j.psychres.2016.08.010"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Larsson S, Aas M, Kungsoyr O et al. Patterns of childhood adverse events are associated with clinical characteristics of bipolar disorder. BMC Psychiatry. 2013;13:97.","DOI":"10.1186\/1471-244X-13-97"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Vocisano C, Klein DN, Keefe RS et al. Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder. Am J Psychiatry. 1996;153(2):248\u2013255.","DOI":"10.1176\/ajp.153.2.248"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:36:37Z","timestamp":1791315397000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/a-retrospective-study-of-mood-and-anxiety-disorders-management-profile-mood-map-of-patients-admitted-at-the-makati-medical-center-from-2014-2017\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.16584","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}